Primary Record
Orantinib
- In stock
- 2,220 g
- Purity
- 99.5 %
- CAS
- 252916-29-3
Compound Identifiers & Properties
- CAS
- 252916-29-3
- PubChem CID
- 5329099
- SMILES
- CC1=C(NC(=C1CCC(=O)O)C)/C=C\2/C3=CC=CC=C3NC2=O
- Canonical SMILES
- Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O
Names & Synonyms
- Orantinib
- TSU-68
- Orantinibum
- (Z)-Orantinib
- 252916-29-3
- Orantinib [INN]
- SU-6668
- SU6668
- 210644-62-5
- TSU 68
- SU 6668
- Orantinib (SU6668)
- Orantinib (TSU-68)
- Orantinib; SU-6668
- RefChem:928252
- Rosiglitazone + metformin
- TSU68
- Orantinib (TSU-68)?
- MFCD09743433
- D0A1AQ
- D0A1ZQ
- UNII-9RL37ZZ665
- AC1NS62A
- ORANTINIB [WHO-DD]
- CHEMBL274654
- 9RL37ZZ665
- cc-447
- MLS006011090
- NSC-702827
- SCHEMBL134661
- SU006668
- BDBM4811
- C18H18N2O3
- DTXSID101017164
- GTPL7816
- orb1301001
- orb1908974
- TUS-68
- NSC 702827
- SCHEMBL26193119
- SCHEMBL29354645
- CHEBI:91088
- TSU-68 (Random Configuration)
- TSU-68 (SU6668, Orantinib)
- TSU-68,SU6668,Orantinib)
- EX-A471
- SU-006668
- SYN1085
- NHFDRBXTEDBWCZ-ZROIWOOFSA-N
- BCPP000059
- HMS3413J06
- HMS3677J06
- AOB87351
- ZINC3834032
- Orantinib (TSU-68, SU6668)
- (Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
- ABP000880
- MFCD03426212
- NSC702827
- NSC763929
- NSC800809
- RS0104
- s1470
- TSU-68 (SU6668)
- TSU-68 - SU6668
- AKOS024457561
- C18-H18-N2-O3
- (Z)-SU6668
- CCG-267578
- CID5329099
- CS-0197
- DB12072
- NSC-763929
- NSC-800809
- SDCCGSBI-0654277.P002
- SU-6597
- CID:5329099
- NCGC00387029-01
- 4CA-1186
- AC-25028
- AS-16238
- BC659953
- BT162331
- HY-10517
- SID:53787898
- SMR004702878
- SY240260
- 3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
- PDGFR Tyrosine Kinase Inhibitor VI, SU6668
- Pdgfr tyrosine kinase inhibitor vi,su6668
- AB0033762
- RT-014974
- NS00069381
- ST24036518
- ST24041377
- SU-6668(TSU-68)/SU6668
- SW219790-1
- X7490
- EC-000.2125
- J1.250.198F
- J1.373.758D
- A10953
- A25512
- W-5401
- 3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
- 1H-Pyrrole-3-propanoic acid, 5-[(Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- 3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid
- 3-(4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl)-2-indolinone
- 5-((1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid
- A879274
- C412603
- 2,4-Dimethyl-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid
- 3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid
- 3-(2,4-dimethyl-5-{[(3Z)-2-oxo-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid
- BRD-K55966568-001-01-3
- BRD-K55966568-001-05-4
- BRD-K55966568-001-06-2
- BRD-K55966568-001-09-6
- Q27088210
- TSU68, SU6668, 252916-29-3
- 1H-Pyrrole-3-propanoic acid, 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-
- 1H-Pyrrole-3-propanoicacid, 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- B0084-409435
- 3-{2,4-Dimethyl-5-[(Z)-(2-Oxo-1,2-Dihydro-3h-Indol-3-Ylidene)methyl]-1h-Pyrrol-3-Yl}propanoic Acid
- (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid
- 3-[2,4-dimethyl-5-[(Z)-(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
- PDGFR Tyrosine Kinase Inhibitor VI, SU6668 - CAS 210644-62-5
- (Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)-propionic acid
- (Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid
- 1044712-39-1
- 3-(2,4-dimethyl-5-{[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid
- (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoicacid
- 2,4-Dimethyl-5-(2-oxoindoline-3-ylidenemethyl)-1H-pyrrole-3-propionic acid
- 2,4-Dimethyl-5-[(2-oxoindoline-3-ylidene)methyl]-1H-pyrrole-3-propanoic acid
- 3-(2,4-dimethyl-5-((Z)-(2-oxo-1H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
- 3-[2,4-dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1h-pyrrol-3-yl]propionic acid
- 3-[2,4-dimethyl-5-[(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
- 3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
- 5-(2-Oxo-2,3-dihydro-1H-indole-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-propionic acid
- 5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid
- (z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1h-pyrrol-3-yl]-propionic acid
- 122320-73-4
- 1H-Pyrrole-3-propanoic acid, 5-((Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-
- 2,4-Dimethyl-5-[(Z)-[2,3-dihydro-2-oxo-1H-indole]-3-ylidenemethyl]-1H-pyrrole-3-propanoic acid
- 245036-27-5
- 3-(2,4-DIMETHYL-5-(((3Z)-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-1H-PYRROL-3-YL)PROPANOIC ACID
- 3-(2,4-dimethyl-5-(((3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
- 3-[2,4-Dimethyl-5-[[(Z)-2,3-dihydro-2-oxo-1H-indole-3-ylidene]methyl]-1H-pyrrole-3-yl]propanoic acid
- 3-[2-[(2,3-Dihydro-2-oxo-1H-indole-3-ylidene)methyl]-3,5-dimethyl-1H-pyrrole-4-yl]propanoic acid
- 3-{2,4-dimethyl-5-[(2-oxo(1H-benzo[d]azolidin-3-ylidene))-methyl]pyrrol-3-yl}propanoic acid
- 3-{2,4-dimethyl-5-[(2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid
- 5-((Z)-1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid
- SU6
- TSU-68; 3-[2,4-Dimethyl-5-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propionic Acid; 3-[4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl]-2-indolinone; 5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid; NSC 702827; Orantinib; SU 6668;